CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

September 24, 2025 9:10 AM

CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today announced a series of transformative advancements as it resumes full-scale operations. With groundbreaking progress on its flagship products, CS-Protect Hydrogel and MEDUSA, alongside a strategic capital raise and enhanced financial reporting, CSDX is poised to capture significant market share in the U.S. and...

Read more

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

September 24, 2025 9:05 AM

Ambience Healthcare today announced the launch of its HCC Compliance Validator. Already live with eight healthcare organizations, the HCC Compliance Validator is a real-time tool that checks whether clinician-selected diagnoses are fully substantiated according to CMS documentation standards. The tool then identifies gaps in documentation for clinicians to address before notes are completed, helping clinicians prepare audit-ready notes.Unlike...

Read more

New York Cancer & Blood Specialists Partners with OncoveryCare to Launch Cancer Survivorship Care

September 24, 2025 9:00 AM

New York Cancer & Blood Specialists (NYCBS), one of the nation's leading community oncology practices, today announced a partnership with OncoveryCare to provide personalized, ongoing care to the NYCBS survivor population. Beginning today, OncoveryCare will work alongside NYCBS oncologists to treat the chronic and late effects of cancer treatment and provide comprehensive cancer follow-up care for NYCBS patients.As cancer diagnoses increase and...

Read more

Who Is the Best Facial Feminization Surgeon in the U.S.?

September 24, 2025 9:00 AM

In the field of facial feminization surgery (FFS), one name has risen to the top of the United States and even the world: Dr. Javad Sajan of Allure Esthetic Plastic Surgery. Dr. Sajan, a Seattle-based plastic surgeon, is widely recognized for pioneering a comprehensive one-stage approach to facial feminization that has set him apart as the nation's best. He is the only surgeon in the U.S. offering full FFS - addressing forehead, brow, nose, jaw,...

Read more

Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection

September 24, 2025 9:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in diabetes detection with its AI Facial Health Risk Estimator.The platform extracts subtle facial biomarkers-including skin tone irregularities, microvascular patterns, and elasticity loss-which correlate with early insulin resistance and Type 2 diabetes risk. By layering these signals with predictive algorithms, MDCE's system delivers a personalized, non-invasive forecast...

Read more

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition

September 24, 2025 9:00 AM

Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) has submitted an orphan drug designation (ODD) application to the U.S. Food and Drug Administration (FDA) for crofelemer, the company's novel prescription drug, for the treatment of diarrhea in adult patients with breast cancer that has metastasized to the brain receiving targeted therapy with or without standard chemotherapy.Within the last ten...

Read more

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

September 24, 2025 9:00 AM

Cholrem Pty Ltd, a biotechnology pioneer dedicated to reversing cardiovascular disease, today announced the publication of a significant observational study demonstrating profound and rapid improvements in patients suffering from Atherosclerotic Cardiovascular Disease (ASCVD) using its proprietary therapy Cavadex® (2-hydroxypropyl-β-cyclodextrin).The study, titled Symptomatic Improvement and Enhanced Quality of Life in Individuals with...

Read more

VSee Health Secures Nasdaq Approval for Continued Listing

September 24, 2025 8:30 AM

VSee Health, Inc. (Nasdaq: VSEE) (the "Company"), a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel") had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing...

Read more

Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital

September 24, 2025 8:00 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of a new capital access program in collaboration with RxERP Financial.The program is available to Wellgistics' network of more than 6,500 independent pharmacies and 200+ U.S. manufacturers, providing up to $350,000 in financing per pharmacy and up to $1 million...

Read more

Dr. Sean Doherty Recognized Among "America’s Best Plastic Surgeons" for the 3rd Year in a Row

September 24, 2025 8:00 AM

Once again Dr. Sean Doherty, board-certified plastic surgeon at the Boston Center for Plastic Surgery, has been recognized as one of "America's Best Plastic Surgeons". For the third consecutive year, Dr. Doherty earned placement on the prestigious list, receiving recognition in two highly competitive categories: Breast Augmentation and Liposuction.This acknowledgment places Dr. Doherty among a select group of surgeons nationwide whose expertise...

Read more

Medicus Pharma Ltd. To Present at Brookline Capital Markets

September 24, 2025 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that members of its executive management team will participate in a live fireside chat on Monday, September 29, 2025, hosted by Kumaraguru (Kumar) Raja, Ph.D., Senior Biotechnology Analyst at Brookline Capital...

Read more

Congress Trying to Limit Marijuana Rescheduling, but DEA Can Still Act Now

September 24, 2025 5:00 AM

An open letter to Administrator Terry Cole and the DEA leadership team.First, credit where it's due. The DEA's frontline work-seizing fentanyl, shutting down cartel pipelines, stopping illicit shipments, and engaging communities all saves lives. Your teams of community outreach specialists, diversion investigators, and lab professionals do mission critical work every day. Thank you. But there's a glaring gap in the current approach: patients...

Read more

ZeptoMetrix Elevates Digital Engagement with Bioz Badges, Gaining Powerful Insights Into Scientific Usage

September 24, 2025 4:00 AM

Bioz, Inc., the leading AI-driven citation engine that transforms scientific research publications into interactive marketing solutions, is proud to highlight its successful collaboration with ZeptoMetrix, an Antylia Scientific company and a trusted provider of innovative quality control materials and diagnostic solutions for infectious disease testing. ZeptoMetrix is strengthening researcher confidence by providing direct access to...

Read more

Caring for Elders, Beyond Medicine: Luna Acupuncture Brings Holistic Pain Solutions to Seniors

September 23, 2025 5:00 PM

Luna Acupuncture & Wellness is strengthening its mission to provide compassionate, natural healthcare by expanding its services to include specific offerings for seniors suffering from chronic pain conditions such as arthritis, neuropathy, and age-related mobility challenges. With thriving clinics in Astoria and Hillsboro, the practice-founded in 2015 by Dr. James Carter-has long been recognized as a trusted destination for integrative, holistic...

Read more

Viemed Healthcare Announces Completion of Share Repurchase Program

September 23, 2025 5:00 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program.On June 9, 2025, the Company announced that its Board of Directors had authorized the repurchase of up to 1,976,441 common shares, representing approximately 5% of the total issued and...

Read more

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

September 23, 2025 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced operational and financial results for the fiscal 2025 full year and fourth quarter. The Company is also providing an update on its planned commercial launch of EXXUA, which it believes to be a novel first-in-class...

Read more

Gelbmann Podiatry Urges Public to Take Foot Health Seriously

September 23, 2025 3:45 PM

Gelbmann Podiatry is using its platform to raise awareness about the importance of foot health and its direct impact on overall well-being. In the recent feature "Finding Inspiration in Every Step: A Q&A with Gelbmann Podiatry," the practice shared stories of patients whose lives were transformed when they regained mobility."Mobility is freedom," Gelbmann Podiatry said. "When someone can walk without pain again, it restores confidence,...

Read more

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025

September 23, 2025 3:40 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2025.Revenue for the quarter ended June 30, 2025 was $14.2 million compared to $12.7 million for the quarter ended June 30, 2024, an increase of $1.5 million or 11.8%. The Company had operating income of approximately $589,000 and $402,000 in the quarters ended June 30, 2025 and 2024,...

Read more

Honey Trick For Memory Explained: Scam or Legit Brain Boosting Hack? Facts, Myths, and Safe Alternatives

September 23, 2025 1:55 PM

The "Honey Trick for Memory" has recently emerged as a trending topic across social media and online platforms, often presented as a simple home remedy capable of boosting memory, reversing forgetfulness, and even addressing age-related cognitive decline. It is usually promoted in eye-catching videos and ads that claim a secret honey recipe can outperform medical treatments or supplements. However, many investigations have revealed that this...

Read more

The Assistance Fund Marks 100th Disease Program, Expands Support to People Living With Macular Degeneration

September 23, 2025 12:00 PM

The Assistance Fund (TAF), an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of its 100th disease program, a new copay assistance program for people living with macular degeneration. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles....

Read more